Dr. Thomas Insel, who directed the National Institute of Psychological Wellbeing from 2002 to 2015 and is also an advisor to and investor in Compass Pathways, a biotechnology corporation running medical trials of psilocybin, the psychoactive element of magic mushrooms, thinks these troubles say more details on Lykos as opposed to copyright field in